Nitric oxide protects against chloroquine resistant Plasmodium yoelii nigeriensis parasites in vitro

Experimental Parasitology

Volumn 105, Issue 3-4, 2003, Pages 184-191

  Awasthi, Aradhana ^a,b,c   Kumar, Ajay ^a,b   Upadhyay, Shakti N ^b   Yamada, Tatsuo ^a   Matsunaga, Yoichi ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Interferon ; Lipopolysaccharide; Malaria infection; Nitric oxide; Plasmodium yoelii nigeriensis; Tenospora cordifolia

Indexed keywords

CHLOROQUINE; GAMMA INTERFERON; IMMUNOMODULATING AGENT; LIPOPOLYSACCHARIDE; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL CELL; ARTICLE; COCULTURE; CONTROLLED STUDY; IMMUNOMODULATION; IN VITRO STUDY; MALARIA; MOUSE; NONHUMAN; PARASITE; PARASITEMIA; PERITONEUM MACROPHAGE; PLANT; PLANT STEM; PLASMODIUM YOELII; PRIORITY JOURNAL; TENOSPORA CORDIFOLIA;

PLASMODIUM YOELII NIGERIENSIS;

EID: 1342329240     PISSN: 00144894     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exppara.2003.12.008     Document Type: Article

References (46)

1. Adams D.O., Hamilton T.A. The cell biology of macrophage activation. Annu. Rev. Immunol. 2:1984;283-318.
2. Balmer P., Phillips H.M., Maestre A.E., McMonagle F.A., Phillips R.S. The effect of nitric oxide on the growth of Plasmodium falciparum, P. chabaudi and P. berghei in vitro. Parasite Immunol. 22(2):2000;97-106.
3. Banzouzi J.T., Prado R., Menan H., Valentin A., Roumestan C., Mallie M., Pelissier Y., Blache Y. In vitro antiplasmodial activity of extracts of Alchornea cordifolia and identification of an active constituent: ellagic acid. J. Ethnopharmacol. 81(3):2002;399-401.
4. Beckerman K.P., Rogers H.W., Corbett J.A., Schreiber R.D., McDaniel M.L., Unanue E.R. Release of nitric oxide during the T cell-independent pathway of macrophage activation. Its role in resistance to Listeria monocytogenes. J. Immunol. 150(3):1993;888-895.
5. Brunet L.R. Nitric oxide in parasitic infections. Int. Immunopharmacol. 1(8):2001;1457-1467.
6. Chintalwar G., Jain A., Sipahimalani A., Banerji A., Sumariwalla P., Ramakrishnan R., Sainis K. An immunologically active arabinogalactan from Tinospora cordifolia. Phytochemistry. 52(6):1999;1089-1093.
7. Cruz-Vega D.E., Aguilar A., Vargas-Villarreala J., Verde-Star M.J., Gonzalez-Garza M.T. Leaf extracts of Carlowrightia cordifolia induce macrophage nitric oxide production. Life Sci. 70(11):2002;1279-1284.
8. Ding W., Shen H., Zhu H., Zhonghua Yu, Fang Yi, Xue Za Zhi Hepatotoxicity and formation of reactive oxygen species induced by Microcystis aeruginosa. Toxin. 32(5):1998;278-288.
9. Ghigo D., Aldieri E., Todde R., Costamagna C., Garbarino G., Pescarmona G., Bosia A. Chloroquine stimulates nitric oxide synthesis in murine, porcine, and human endothelial cells. J. Clin. Invest. 102(3):1998;595-605.
10. 15N]nitrate in biological fluids. Anal. Biochem. 126(1):1982;131-138.
11. Green S.J., Nacy C.A., Meltzer M.S. Cytokine-induced synthesis of nitrogen oxides in macrophages: a protective host response to Leishmania and other intracellular pathogens. J. Leukoc. Biol. 50(1):1991;93-103.
12. Griffith O.W., Stuehr D.J. Nitric oxide synthases: properties and catalytic mechanism. Annu. Rev. Physiol. 57:1995;707-736.
13. Gyan B., Troye-Blomberg M., Perlmann P., Bjorkman A. Human monocytes cultured with and without interferon-gamma inhibit Plasmodium falciparum parasite growth in vitro via secretion of reactive nitrogen intermediates. Parasite Immunol. 16(7):1994;371-375.
14. Hibbs J.B. Jr. Synthesis of nitric oxide from L-arginine: a recently discovered pathway induced by cytokines with antitumour and antimicrobial activity. Res. Immunol. 142(7):1991;565-569. discussion 596-598.
15. Hibbs, J.B. Jr., 2002. Infection and nitric oxide. J. Infect. Dis. 15 (185, Suppl. 1), S9-S17.
16. Hill J. Chemotherapy of malaria Part-II. The antimalarial drugs. Schnitzer R.J., Hawking R. Experimental Chemoterapy. vol. I:1963;513-601 Academic Press, New York.
17. Ignarro L.J. Haem-dependent activation of guanylate cyclase and cyclic GMP formation by endogenous nitric oxide: a unique transduction mechanism for transcellular signaling. Pharmacol. Toxicol. 67(1):1990;1-7.
18. Kun J.F., Mordmuller B., Perkins D.J., May J., Mercereau-Puijalon O., Alpers M., Weinberg J.B., Kremsner P.G. Nitric oxide synthase 2(Lambarene) (G-954C), increased nitric oxide production, and protection against malaria. J. Infect. Dis. 184(3):2001;330-336.
19. Kwon N.S., Stuehr D.J., Nathan C.F. Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide. J. Exp. Med. 174(4):1991;761-767.
20. Liew F.Y., Li Y., Moss D., Parkinson C., Rogers M.V., Moncada S. Resistance to Leishmania major infection correlates with the induction of nitric oxide synthase in murine macrophages. Eur. J. Immunol. 21(12):1991;3009-3014.
21. Liew F.Y., Li Y., Severn A., Millott S., Schmidt J., Salter M., Moncada S. A possible novel pathway of regulation by murine T helper type-2 (Th2) cells of a Th1 cell activity via the modulation of the induction of nitric oxide synthase on macrophages. Eur. J. Immunol. 21(10):1991;2489-2494.
22. Mellouk S., Green S.J., Nacy C.A., Hoffman S.L. IFN-gamma inhibits development of Plasmodium berghei exoerythrocytic stages in hepatocytes by an L-arginine-dependent effector mechanism. J. Immunol. 146(11):1991;3971-3976.
23. Moncada S., Palmer R.M., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43(2):1991;109-142.
24. Mustofa V.A., Benoit-Vical F., Pelissier Y., Kone-Bamba D., Mallie M. Antiplasmodial activity of plant extracts used in west African traditional medicine. J. Ethnopharmacol. 73(1-2):2000;145-151.
25. Nahrevanian H., Dascombe M.J. Nitric oxide and reactive nitrogen intermediates during lethal and nonlethal strains of murine malaria. Parasite Immunol. 23(9):2001;491-501.
26. Nathan C.F., Hibbs J.B. Jr. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol. 3(1):1991;65-70.
27. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6(12):1992;3051-3064.
28. Nussler A., Drapier J.C., Renia L., Pied S., Miltgen F., Gentilini M., Mazier D. L-Arginine-dependent destruction of intrahepatic malaria parasites in response to tumor necrosis factor and/or interleukin 6 stimulation. Eur. J. Immunol. 21(1):1991;227-230.
29. Pande A., Dutta G.P. Chemotherapeutic response of Plasmodium yoelii nigeriensis to antimalarial drugs. Ind. J. Malarial. 1982;121-124.
30. Park Y.C., Pae H.O., Yoo J.C., Choi B.M., Jue D.M., Chung H.T. Chloroquine inhibits inducible nitric oxide synthase expression in murine peritoneal macrophages. Pharmacol. Toxicol. 85(4):1999;188-191.
31. Philippe J., Debruyne J., Leroux-Roels G., Willems A., Dereuck J. In vitro TNF-alpha, IL-2 and IFN-gamma production as markers of relapses in multiple sclerosis. Clin. Neurol. Neurosurg. 98(4):1996;286-290.
32. Rockett K.A., Targett G.A., Playfair J.H. Killing of blood-stage Plasmodium falciparum by lipid peroxides from tumor necrosis serum. Infect. Immun. 56(12):1988;3180-3183.
33. Rockett K.A., Awburn M.M., Cowden W.B., Clark I.A. Killing of Plasmodium falciparum in vitro by nitric oxide derivatives. Infect. Immun. 59(9):1991;3280-3283.
34. Rockett K.A., Awburn M.M., Aggarwal B.B., Cowden W.B., Clark I.A. In vivo induction of nitrite and nitrate by tumor necrosis factor, lymphotoxin, and interleukin-1: possible roles in malaria. Infect. Immun. 60(9):1992;3725-3730.
35. Rockett K.A., Awburn M.M., Rockett E.J., Cowden W.B., Clark I.A. Possible role of nitric oxide in malarial immunosuppression. Parasite Immunol. 16(5):1994;243-249.
36. Rubin H., Salem J.S., Li L.S., Yang F.D., Mama S., Wang Z.M., Fisher A., Hamann C.S., Cooperman B.S. Cloning, sequence determination, and regulation of the ribonucleotide reductase subunits from Plasmodium falciparum: a target for antimalarial therapy. Proc. Natl. Acad. Sci. USA. 90(20):1993;9280-9284.
37. Sano H., Hirai M., Saito H., Nakashima I., Isobe K.I. A nitric oxide-releasing reagent, S-nitroso-N-acetylpenicillamine, enhances the expression of superoxide dismutases mRNA in the murine macrophage cell line RAW264-7. Immunology. 92(1):1997;118-122.
38. Stevenson M.M., Tam M.F., Wolf S.F., Sher A. IL-12-induced protection against blood-stage Plasmodium chabaudi AS requires IFN-gamma and TNF-alpha and occurs via a nitric oxide-dependent mechanism. J. Immunol. 155(5):1995;2545- 2556.
39. Stuehr D.J., Griffith O.W. Mammalian nitric oxide synthases. Adv. Enzymol. Relat. Areas Mol. Biol. 65:1992;287-346.
40. Subramanian M., Chintalwar G.J., Chattopadhyay S. Antioxidant properties of a Tinospora cordifolia polysaccharide against iron-mediated lipid damage and gamma-ray induced protein damage. Redox Rep. 7(3):2002;137-143.
41. Tan R.S., Kara A.U., Feng C., Asano Y., Sinniah R. Differential interleukin-10 expression in interferon regulatory factor-1 deficient mice during Plasmodium berghei blood-stage infection. Parasite Immunol. 22(9):2000;425-435.
42. Taylor-Robinson A.W., Phillips R.S., Severn A., Moncada S., Liew F.Y. The role of TH1 and TH2 cells in a rodent malaria infection. Science. 260(5116):1993;1931-1934.
43. Taylor-Robinson A.W. The sequestration hypothesis: an explanation for the sensitivity of malaria parasites to nitric oxide-mediated immune effector function in vivo. Med. Hypotheses. 54(4):2000;638-641.
44. Traylor T.G., Sharma V.S. Why NO? Biochemistry. 31(11):1992;2847-2849.
45. Wakita K., Minami M., Venkateswarlu A., Sharma V.M., Ramesh M., Akahane K. Antitumor bicyclic hexapeptide RA-VII modulates cyclin D1 protein level. Anticancer Drugs. 12(5):2001;433-439.
46. Weber S.M., Levitz S.M. Chloroquine interferes with lipopolysaccharide- induced TNF-alpha gene expression by a nonlysosomotropic mechanism. J. Immunol. 165(3):2000;1534-1540.